Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006;1(3):247-51.
doi: 10.2147/ciia.2006.1.3.247.

Citicoline (Cognizin) in the treatment of cognitive impairment

Mario Fioravanti  1 , Ann E Buckley
Affiliations
Review

Citicoline (Cognizin) in the treatment of cognitive impairment

Mario Fioravanti et al. Clin Interv Aging. 2006.

Abstract

Pharmacological treatment of cerebrovascular disorders was introduced at the beginning of the 20th Century. Since then, a multitude of studies have focused on the development of a consensus for a well defined taxonomy of these disorders and on the identification of specific patterns of cognitive deficits associated with them, but with no clear consensus. Nevertheless, citicoline has proved to be a valid treatment in patients with a cerebrovascular pathogenesis for memory disorders. A metanalysis performed on the entire database available from the clinical studies performed with this compound confirms the experimental evidence from the animal studies which have repeatedly described the multiple biological actions of citicoline in restoring both the cell lipid structures and some neurotransmitter functions.

PubMed Disclaimer

References

    1. Abad-Santos F, Novalbos-Reina J, Gallego-Sandin S, et al. Tratamiento del deterioro cognitivo lieve: utilidad de la citicolina. Rev Neurol. 2002;35:675–82. - PubMed
    1. Agnoli A, Bruno G, Fioravanti M. Therapeutic approach to senile memory impairment: a double-blind clinical trial with CDP-choline. In: Wurtman RJ, Corkin S, Growdon JH, et al., editors. Alzheimer’s disease: proceedings of the fifth meeting of the International Study Group in the Pharmacology of Memory Disorders Associated with Aging. Boston: Birkhauser; 1986. pp. 649–54.
    1. Bettini R, Gorini M. I tempi di reazione durante il trattamento con citicolina. Clin Ter. 2002;153:247–50. - PubMed
    1. Blount PJ, Nguyen CD, McDeavitt JT. Clinical use of cholinomimetic agents: a review. J Head Trauma Rehabil. 2002;17:314–21. - PubMed
    1. Cavum S, Savci V. CDP.choline increases plasma ACTH and potentiates the stimulated release of GH, TSH, and LH: the cholinergic involvement. Fundam Clin Pharmacol. 2004;18:513–23. - PubMed

MeSH terms

Substances

LinkOut - more resources